首页> 外文期刊>Cancer biology & therapy >Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines.
【24h】

Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell lines.

机译:由于在人乳腺癌细胞系中增加的溶解度,γ-微管蛋白的脱域。

获取原文
获取原文并翻译 | 示例
       

摘要

The centrosome is the major organelle responsible for the nucleation and organization of microtubules into arrays. Recent studies demonstrate that microtubules can nucleate outside the centrosome. The molecular mechanisms controlling acentrosomal microtubule nucleation are currently poorly defined, and the function of this type of microtubule regulation in tumor cell biology is particularly unclear. Since microtubule nucleation is initiated by the gamma-tubulin protein, we examined the regulation of gamma-tubulin in a panel of human breast tumor cell lines, ranging from non-tumorigenic to highly aggressive. We have identified a more dispersive subcellular localization of gamma-tubulin in aggressive breast cancer cell lines, while gamma-tubulin localization remains largely centrosomal in non-aggressive cell lines. Delocalization of gamma-tubulin occurs independently from changes in protein expression and is therefore regulated at the post-translational level. Subcellular fractionation revealed that tumor cell lines show an aberrantly increased release of gamma-tubulin into a soluble cytoplasmic fraction, with the most dramatic changes observed in tumor cell lines of greater aggressiveness. Extraction of soluble gamma-tubulin revealed acentrosomal incorporation of gamma-tubulin in cytoplasmic microtubules and along cell junctions. Moreover, acentrosomal delocalization of gamma-tubulin yielded resistance to colchicine-mediated microtubule collapse. These findings support a model where the solubility of gamma-tubulin can be altered through post-translational modification and provides a new mechanism for microtubule dysregulation in breast cancer. Gamma-tubulin that is delocalized from the centrosome can still clearly be incorporated into filaments, and defines a novel mechanism for tumor cells to develop resistance to microtubule-targeted chemotherapies.
机译:中心体是负责将微管成核和组织成阵列的主要细胞器。最近的研究表明,微管可以在中心体外成核。目前尚不清楚控制人小体上微管成核的分子机制,这种类型的微管调节在肿瘤细胞生物学中的功能尚不清楚。由于微管成核是由γ-微管蛋白启动的,因此我们研究了人类乳腺肿瘤细胞系中从非致瘤性到高度侵袭性的γ-微管蛋白的调控。我们已经确定了侵略性乳腺癌细胞系中γ-微管蛋白的更分散的亚细胞定位,而γ-微管蛋白的本地化在非侵袭性细胞系中仍然大部分为中心体。 γ-微管蛋白的离域独立于蛋白质表达的变化而发生,因此在翻译后水平受到调控。亚细胞分级显示肿瘤细胞系显示出γ-微管蛋白向可溶性细胞质部分的释放异常增加,在侵袭性更大的肿瘤细胞系中观察到最显着的变化。可溶性γ-微管蛋白的提取显示γ-微管蛋白在细胞质微管中和沿细胞连接处的中心体结合。此外,γ-微管蛋白在人染色体上的离域产生了对秋水仙碱介导的微管塌陷的抗性。这些发现支持了一种模型,其中γ-微管蛋白的溶解度可以通过翻译后修饰来改变,并为乳腺癌中微管失调提供了新的机制。从中心体脱位的γ-微管蛋白仍可以清楚地整合到细丝中,并为肿瘤细胞发展了针对微管靶向化疗的耐药性定义了新的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号